Meta-analysisindependent cross-checkabstract only checked★ key study I-INTB-09 in-depth review

Skipping transplant drugs often leads to losing the kidney

Frequency and impact of nonadherence to immunosuppressants after renal transplantation: a systematic review.

Overview

Butler JA et al.. Transplantation 2004 · PMID 15021846 · DOI 10.1097/01.tp.0000110408.83054.88

Not taking immunosuppressants was linked to about seven times higher odds of graft failure.

Does the study support the specific claim? No · Methodological quality: moderate

Original publication

Plain-language summary

Study explained simply
What did the researchers want to find out?

Measure impact of nonadherence

How was the study done?

Systematic review

How many people, animals or samples were studied?

36 studies

What was actually found?

Nonadherence common; strongly linked to graft loss

How large was the observed effect?

about 7-fold odds of graft failure

What do the results mean in everyday life?

Transplant medicines protect the new kidney; stopping them is a major cause of losing it.

What are the study's limitations?

Self-report measures; abstract only

What does it say about Elawady's specific claim?

Contradicts stopping immunosuppression.

Do the results apply to Germany and Europe?

High

What can explicitly not be concluded from this study?

Cannot predict the outcome for one individual patient.

Scientific in-depth review

1. Full reference

Authors
Butler JA et al.
Journal
Transplantation
Year
2004
Identifier
PMID 15021846 DOI 10.1097/01.tp.0000110408.83054.88
Verification
verified – PubMed efetch 2026-10-25
Retracted
no
Corrections
none
Extent checked
abstract only
Conflicts of interest and funding

Research Support, Non-U.S. Gov't (publication type); no COI statement in record

2. Research question

How frequent is nonadherence to immunosuppressants after kidney transplantation and how does it affect graft survival?

3. Study design and population

Study design
Meta-analysis – Systematic review with meta-analysis of cohort studies
Population

Adult kidney-transplant recipients

Country

Multinational

Period

studies 1980-2001

Sample size

36 studies included (325 screened)

Inclusion and exclusion criteria

Adult renal transplant recipients; studies reporting frequency or impact of nonadherence

4. Methods and endpoints

Exposure / intervention

Nonadherence to immunosuppressants

Comparator

Adherent recipients

Endpoints

Graft failure

Statistical methods

Meta-analysis of cohort studies

5. Actual results

Results

Median 22% (IQR 18-26%) of recipients were nonadherent in cross-sectional studies. In cohort studies a median 36% (IQR 14-65%) of graft losses were associated with prior nonadherence. Odds of graft failure increased sevenfold in nonadherent vs adherent recipients (95% CI reported as '4%-12%' in the abstract, presumably 4-12-fold).

Absolute risks

Median 36% of graft losses associated with prior nonadherence

Authors' conclusion

Nonadherence is common and has a large impact on transplant survival.

6. Strengths

  • Systematic search
  • Quantitative synthesis

7. Weaknesses

  • Adherence measurement mostly self-report
  • Older studies
  • Abstract only read

8. Risk of bias

Orienting tool
AMSTAR 2
Type of assessment
simplified assessment (abstract only)
Full formal assessment
no
Overall risk of bias
some concerns
Rationale

Measurement heterogeneity; observational data.

9. Assessment of the statistical interpretation

Large, consistent association; observational, but complete stopping of immunosuppression cannot ethically be randomised.

10. Relevance to the specific claim

Directly contradicts the idea that stopping immunosuppression is safe for a transplanted kidney.

11. Independent contrary findings

Rare 'operationally tolerant' patients exist (general transplant knowledge, not sourced here).

12. Transferability to Germany and Europe

High; same immunology.

13. Overall methodological judgement

Strong evidence that not taking immunosuppressants leads to graft loss.

Multidimensional assessment
Multidimensional assessment
Authenticity of the sourceverified
Methodological qualitymoderate
Risk of biassome concerns
Precision of resultsmoderate
Directnessdirect
Reproducibilityreplicated
Consistency with the overall evidenceconsistent
Regional transferabilityhigh
Adequacy of the interpretation (by the archive)not applicable

14. Open questions

Threshold of adherence that matters.

15. Linked fact checks